NCT04450849

Brief Summary

Periodontal disease is an infectious-inflammatory disease that accommodates the supporting and supporting tissues of the teeth, with the formation of periodontal pockets, and this destruction can generate anatomical defects in the region of bifurcation. Treatment of these lesions is a challenge for the clinician, as this area has limited access to bacterial biofilm and calculus. The surgical regenerative therapy using bone grafts and membrane may be a viable option in cases of class II furcation defects. In this context, the objective of this case series is to evaluate tomographically and clinically the treatment of class II furcation defects using an absorbable collagen membrane (Bio-Gide® Perio) associated or not with inorganic bovine bone associated with collagen matrix (Bio-Oss® Collagen).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2018

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
Last Updated

June 30, 2020

Status Verified

June 1, 2020

Enrollment Period

1.4 years

First QC Date

June 21, 2020

Last Update Submit

June 24, 2020

Conditions

Keywords

periodontal diseasesPeriodontitisperiodontal regeneration

Outcome Measures

Primary Outcomes (1)

  • to evaluate clinical attachment level

    Change from Baseline in clinical attachment level at +360 days

    The clinical periodontal parameter will be recorded at baseline (pre-intervention) and +360 days after the surgical periodontal therapy.]

Secondary Outcomes (1)

  • Tomographic bone gain

    The Tomographic bone gain parameter will be recorded at baseline (pre-intervention) and +360 days after the surgical periodontal therapy.]

Study Arms (2)

collagen membrane associated to anorganic bone

EXPERIMENTAL

Complete debridement of the osseous defects and thorough scaling and root planing using mini curettes and ultrasonic scalers were performed. The sites were randomly selected for treatment with resorbable collagen membrane (Bio-Gide® Perio) associated to anorganic bovine bone matrix + collagen (Bio-Oss® Collagen) . The membranes were trimmed to cover the lesions and extended to the adjacent bone between 2 to 3 mm apically and laterally. They were then placed in position, 2 mm below the CEJ, and fixed in position using sling 5-0 vicryl sutures. The flaps were coronally positioned until completely covering the membranes without tension and sutured with 5-0 nylon sutures

Procedure: guided tissue regeneration with using an absorbable collagen membrane associated with inorganic bovine bone associated.

collagen membrane alone

ACTIVE COMPARATOR

Complete debridement of the osseous defects and thorough scaling and root planing using mini curettes and ultrasonic scalers were performed. The sites were randomly selected for treatment with resorbable collagen membrane (Bio-Gide® Perio). The membranes were trimmed to cover the lesions and extended to the adjacent bone between 2 to 3 mm apically and laterally. They were then placed in position, 2 mm below the CEJ, and fixed in position using sling 5-0 vicryl sutures. The flaps were coronally positioned until completely covering the membranes without tension and sutured with 5-0 nylon sutures

Procedure: guided tissue regeneration with using an absorbable collagen membrane associated or not with inorganic bovine bone associated with collagen matrix.

Interventions

Dental surgical procedures that use barrier membranes to direct the growth of new bone and gingival tissue at sites with insufficient volumes or dimensions of bone or gingiva for proper function, esthetics or prosthetic restoration. Using an absorbable collagen membrane (Bio-Gide® Perio) associated with inorganic bovine bone associated with collagen matrix (Bio-Oss® Collagen).

Also known as: GTR
collagen membrane associated to anorganic bone

dental surgical procedures that use barrier membranes to direct the growth of new bone and gingival tissue at sites with insufficient volumes or dimensions of bone or gingiva for proper function, esthetics or prosthetic restoration. Using an absorbable collagen membrane (Bio-Gide® Perio) alone.

Also known as: GTR
collagen membrane alone

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subjects with a diagnosis of periodontitis, Stage III and Grade A (according to the 2018 international classification criteria);
  • presence of one mandibular molar with class II buccal furcation defect;
  • non-smokers;
  • plaque index \<20%.

You may not qualify if:

  • patients that presented systemic diseases;
  • patients that had taken antibiotics in the past 6 months prior to surgical procedures;
  • pregnant women or lactating mothers;
  • furcation involvement in molars with periapical disease;
  • cervical restorations or prosthesis closer than 1 mm to fornix.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sao Paulo

São Paulo, São Paulo, 14040-904, Brazil

Location

MeSH Terms

Conditions

Periodontal DiseasesBone DiseasesPeriodontitis

Interventions

Guided Tissue RegenerationNuclear Receptor Subfamily 4, Group A, Member 2

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Plastic Surgery ProceduresSurgical Procedures, OperativeOrphan Nuclear ReceptorsDNA-Binding ProteinsProteinsAmino Acids, Peptides, and ProteinsReceptors, Cytoplasmic and Nuclear

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In a parallel design, 22 patients with mandibular class II furcation defects were recruited. Each defect was randomly assigned to the control group (CG - Bio-Gide® Perio, n=11) or test group (TG - Bio-Oss® Collagen + Bio-Gide® Perio, n=11). Tomographic and clinical evaluations were conducted at baseline and 12 months post-surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Departament of Oral & Maxillofacial Surgery and Periodontology

Study Record Dates

First Submitted

June 21, 2020

First Posted

June 30, 2020

Study Start

January 10, 2018

Primary Completion

June 15, 2019

Study Completion

January 20, 2020

Last Updated

June 30, 2020

Record last verified: 2020-06

Locations